Discovery of new inhibitors of eef2k from traditional chinese medicine based on in silico screening and in vitro experimental validation

HIGHLIGHTS

• who: Qinghua Fu and collaborators from the State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, College of Animal Science and Technology, Guangxi University, Nanning, China have published the article: Discovery of New Inhibitors of eEF2K from Traditional Chinese Medicine Based on In Silico Screening and In Vitro Experimental Validation, in the Journal: Molecules 2022, 4886 of 29/07/2022
• what: To test the effects of the chemicals on eEF2K activity, the authors focused on the alteration of phosphorylation levels of eEF2, which is a primary downstream target of eEF2K and is often . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.